Bluesky Β· Hashtag

#NephJC

41
posts Β· 30d
9
users
1
posts / day
4.6
posts / user
+ 1300% vs last week

#NephJC is an active hashtag on Bluesky. In the last 30 days, 9 people shared 41 posts with it β€” around 1 a day. Activity is up 1300% versus the previous week, peaking on Nov 4 with 8 posts.

#NephJC posts per day (last 30 days)

Related tags

Tags most often used together with #NephJC.

Posts with #NephJC

David W (aka Flex NP)
@rnflex.bsky.social
4 days ago
Those are extremely impressive blood pressure reductions for a drug designed for weight loss! Up to 15mmHg ⬇️ for stage 2 hypertension in obesity(Attain-1) or diabetes(Attain-2) #NephJC The phase 3 hypertension trials also includes detailed renal substudy to figure out the mechanism at play here.
0 0 4
Nephrology Journal Club
@nephjc.bsky.social
5 days ago
1/10 #NephJC #TenPosts 🫘 Intermittent HD or continuous RRT for critically ill patients with AKI? βš–οΈ For years, trials suggested similar outcomes. Does the choice of modality affect survival? πŸ’₯ The ICRAKI trial challenges previous evidence www.nejm.org/doi/10.1056/... #NephJC #TenPosts
1 2 3
Nephrology Journal Club
@nephjc.bsky.social
7 days ago
IHD vs CRRT again. ICRAKI was stopped early due to higher mortality with IHD. Real signal or truncation artifact? And was IHD given the way we'd give it to a patient on vasopressors? #NephJC #nephsky ✍️ @rnflex.bsky.social @divyaveerssneph.bsky.social www.nephjc.com/news/icraki1...
ICRAKI-ng the code on RRT β€” NephJC

www.nephjc.com

ICRAKI-ng the code on RRT β€” NephJC

This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)

0 7 6
Nephrology Journal Club
@nephjc.bsky.social
5 days ago
11/10 #NephJC Poll In your ICU, which RRT modality is most commonly used for hemodynamically unstable patients with AKI? πŸ”˜ CRRT πŸ”˜ SLED πŸ”˜ IHD πŸ’¬ Does the ICRAKI trial make you reconsider your current practice?
1 1 1
Rolando Claure
@runningkidneys.bsky.social
5 days ago
ICRAKI challenges our approach to KRT in severe AKI: IHD did not meet noninferiority for MAKE90; a mortality signal favored CRRT, but early stopping limits inference. The IHD prescription matters. Excellent critical appraisal by #NephJC. www.nephjc.com/news/icraki1...
ICRAKI-ng the code on RRT β€” NephJC

www.nephjc.com

ICRAKI-ng the code on RRT β€” NephJC

This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)

0 0 0
Nephrology Journal Club
@nephjc.bsky.social
5 days ago
9/10 I want more info πŸ“– Read the full ICRAKI trial: Gaudry S et al. Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury. NEJM, 2026. πŸ”— DOI: 10.1056/NEJMoa2608397 🫘 Check out the #NephJC discussion! @DivyaveerSSNeph @rn_flex www.nephjc.com/news/icraki1...
ICRAKI-ng the code on RRT β€” NephJC

www.nephjc.com

ICRAKI-ng the code on RRT β€” NephJC

This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)

1 0 0
Nephrology Journal Club
@nephjc.bsky.social
5 days ago
8/10 ⚠️ #NephJC Consensus πŸ’‘ Strengths: randomized, multicenter, contemporary trial with clear RRT indications ⚠️ Limitations: early termination, open-label design, treatment crossover and slightly subtarget IHD dose 🫘 Kidney-specific outcomes remain uncertain
1 0 0
Nephrology Journal Club
@nephjc.bsky.social
5 days ago
7/10 Question 2 #NephJC #NephSky ❓ Could hemodynamic instability explain the mortality difference? πŸ’‰ Post hoc analyses suggested greater catecholamine requirements with IHD ⚠️ But no clear treatment-effect heterogeneity was observed by baseline catecholamine support
1 0 0

Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.